Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bin Qiu

Showing results (611-620 of 635) with videos related to

Pageof 64
Sort By:
Journal of Cancer Research and Therapeutics|June 4, 2026
Expert consensus on robotic radiosurgery system for hepatocellular carcinomaBin Qiu, Yuliang Jiang, Zuping Lian, et al.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|September 1, 2023
[Effect of High-Concentration Uric Acid on Nitric Oxide]Si-Yu Qin, Rong-Yu Lan, Jia Zeng, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 18, 2025
Advantages of robotic-assisted thoracic surgery after neoadjuvant therapy in NSCLC: A propensity score-matched analysisHong-Ji Li, Jia-Yan Ding, Qiang Nie, et al.
Urologic Oncology|September 17, 2016
miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinomaNing Lou, An-Ming Ruan, Bin Qiu, et al.
Molecular & Cellular Proteomics : MCP|November 9, 2011
Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysisFengwei Tan, Ying Jiang, Nan Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2013
Isocitrate dehydrogenase 1 is a novel plasma biomarker for the diagnosis of non-small cell lung cancerNan Sun, Zhaoli Chen, Fengwei Tan, et al.
BMC Cancer|January 24, 2018
Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinomaGuang-Hua Xu, Ning Lou, Hang-Chuan Shi, et al.
BMJ Open|November 19, 2015
Open three-stage transthoracic oesophagectomy versus minimally invasive thoraco-laparoscopic oesophagectomy for oesophageal cancer: protocol for a multicentre prospective, open and parallel, randomised controlled trialJuwei Mu, Shugeng Gao, Yousheng Mao, et al.
Cancer Medicine|May 2, 2026
Age-Associated Targetable Genomic Alterations and PD-L1 Expression in 2509 Patients With Pulmonary Ground-Glass OpacitiesWen-Fang Tang, Si-Qi Huang, Yi-Duo Lin, et al.
Msystems|December 23, 2025
Comprehensive profiling of antibiotic resistance, virulence genes, and mobile genetic elements in the gut microbiome of Tibetan antelopesJian Liu, Hong-Bo Ni, Ming-Yuan Yu, et al.
Pageof 64

Showing results (611-620 of 635) with videos related to

Sort By:
Pageof 64
Journal of Cancer Research and Therapeutics|June 4, 2026
Expert consensus on robotic radiosurgery system for hepatocellular carcinomaBin Qiu, Yuliang Jiang, Zuping Lian, et al.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|September 1, 2023
[Effect of High-Concentration Uric Acid on Nitric Oxide]Si-Yu Qin, Rong-Yu Lan, Jia Zeng, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 18, 2025
Advantages of robotic-assisted thoracic surgery after neoadjuvant therapy in NSCLC: A propensity score-matched analysisHong-Ji Li, Jia-Yan Ding, Qiang Nie, et al.
Urologic Oncology|September 17, 2016
miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinomaNing Lou, An-Ming Ruan, Bin Qiu, et al.
Molecular & Cellular Proteomics : MCP|November 9, 2011
Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysisFengwei Tan, Ying Jiang, Nan Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2013
Isocitrate dehydrogenase 1 is a novel plasma biomarker for the diagnosis of non-small cell lung cancerNan Sun, Zhaoli Chen, Fengwei Tan, et al.
BMC Cancer|January 24, 2018
Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinomaGuang-Hua Xu, Ning Lou, Hang-Chuan Shi, et al.
BMJ Open|November 19, 2015
Open three-stage transthoracic oesophagectomy versus minimally invasive thoraco-laparoscopic oesophagectomy for oesophageal cancer: protocol for a multicentre prospective, open and parallel, randomised controlled trialJuwei Mu, Shugeng Gao, Yousheng Mao, et al.
Cancer Medicine|May 2, 2026
Age-Associated Targetable Genomic Alterations and PD-L1 Expression in 2509 Patients With Pulmonary Ground-Glass OpacitiesWen-Fang Tang, Si-Qi Huang, Yi-Duo Lin, et al.
Msystems|December 23, 2025
Comprehensive profiling of antibiotic resistance, virulence genes, and mobile genetic elements in the gut microbiome of Tibetan antelopesJian Liu, Hong-Bo Ni, Ming-Yuan Yu, et al.
Pageof 64